Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2025-11-14
• Last 15 days FTD volume: £25.19 M
• Last 3 months FTD volume: £42.51 M
• Last 12 months FTD volume: £96.84 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	£60.15 M	£0.26 B	🇺🇸 USA
AbbVie ABBV	£21.44 M	£0.10 B	🇺🇸 USA
Merck MRK	£33.81 M	£0.17 B	🇺🇸 USA
Bristol-Myers Squibb BMY	£6.09 M	£0.21 B	🇺🇸 USA
Johnson & Johnson JNJ	£54.31 M	£94.31 M	🇺🇸 USA
Enanta Pharmaceuticals ENTA	£0.57 M	£0.98 M	🇺🇸 USA